Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Feb-23 6:38 PM View:  | Harris Chad Everett (SEE REMARKS) | AspenBio Pharma Inc. (RIOT) | 01-Feb-23 | Disposition | 960,942 | -- | -- | (99%) 975.34K to 14.4K | |
| 19-Jan-23 6:50 PM View: | d'Ambrosio Lance Varro Director | AspenBio Pharma Inc. (RIOT) | 17-Jan-23 | Sale (Planned) | 26,000 | $6.39 | $166,101.00 | (27%) 95.44K to 69.44K | |
| 13-Jan-23 6:40 PM View: | Harris Chad Everett EVP, CCO | AspenBio Pharma Inc. (RIOT) | 11-Jan-23 | Payment of Exercise | 9,600 | $4.22 | $40,512.00 | (< 1%) 984.94K to 975.34K | |
| 13-Jan-23 6:41 PM View: | McGonegal Jefferey Senior Advisor | AspenBio Pharma Inc. (RIOT) | 11-Jan-23 | Payment of Exercise | 13,200 | $4.22 | $55,704.00 | (1%) 889.48K to 876.28K | |
| 13-Jan-23 6:40 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 11-Jan-23 | Payment of Exercise | 12,000 | $4.22 | $50,640.00 | (1%) 1.02M to 1.01M | |
| 13-Jan-23 6:42 PM View: | Werner Ryan D. SVP, CAO | AspenBio Pharma Inc. (RIOT) | 11-Jan-23 | Payment of Exercise | 7,200 | $4.22 | $30,384.00 | (2%) 342.92K to 335.72K | |
| 13-Jan-23 6:41 PM View: | Les Jason Chief Executive Officer Director | AspenBio Pharma Inc. (RIOT) | 11-Jan-23 | Payment of Exercise | 16,667 | $4.22 | $70,334.70 | (< 1%) 3.81M to 3.8M | |
| 04-Jan-23 6:11 PM View: | Marleau Hubert Director | AspenBio Pharma Inc. (RIOT) | 31-Dec-22 | Payment of Exercise | 15,493 | $3.39 | $52,521.30 | (14%) 108.45K to 92.95K | |
| 04-Jan-23 6:09 PM View: | Cho Hannah Director | AspenBio Pharma Inc. (RIOT) | 31-Dec-22 | Payment of Exercise | 15,493 | $3.39 | $52,521.30 | (14%) 111.57K to 96.08K | |
| 19-Dec-22 5:44 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 15-Dec-22 | Sale | 25,000 | $4.00 | $100,000.00 | (2%) 1.04M to 1.02M | |
| 09-Dec-22 5:45 PM View: | Harris Chad Everett EVP, CCO | AspenBio Pharma Inc. (RIOT) | 07-Dec-22 | Sale | 75,565 | $4.15 | $313,595.00 | (7%) 1.06M to 984.94K | |
| 01-Nov-22 7:50 PM View: | d'Ambrosio Lance Varro Director | AspenBio Pharma Inc. (RIOT) | 31-Oct-22 | Sale (Planned) | 26,000 | $6.97 | $181,220.00 | (21%) 121.44K to 95.44K | |
| 04-Oct-22 6:26 PM View: | Marleau Hubert Director | AspenBio Pharma Inc. (RIOT) | 01-Oct-22 | Payment of Exercise | 13,930 | $7.01 | $97,649.30 | (11%) 122.38K to 108.45K | |
| 04-Oct-22 6:25 PM View: | Cho Hannah Director | AspenBio Pharma Inc. (RIOT) | 01-Oct-22 | Payment of Exercise | 13,930 | $7.01 | $97,649.30 | (11%) 125.5K to 111.57K | |
| 04-Oct-22 6:26 PM View: | Marleau Hubert Director | AspenBio Pharma Inc. (RIOT) | 30-Sep-22 | Payment of Exercise | 1,563 | $7.01 | $10,956.60 | (1%) 123.94K to 122.38K | |
| 04-Oct-22 6:25 PM View: | Cho Hannah Director | AspenBio Pharma Inc. (RIOT) | 30-Sep-22 | Payment of Exercise | 1,563 | $7.01 | $10,956.60 | (1%) 127.07K to 125.5K | |
| 29-Sep-22 9:00 PM View: | Marleau Hubert Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 111,441 | -- | -- | 100% 0 to 111.44K | |
| 29-Sep-22 8:58 PM View: | McGonegal Jefferey CFO (Former - See Remarks) | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 222,883 | -- | -- | 65% 343.26K to 566.15K | |
| 29-Sep-22 9:00 PM View: | Marleau Hubert Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 12,500 | -- | -- | 11% 111.44K to 123.94K | |
| 29-Sep-22 8:45 PM View: | Cho Hannah Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Payment of Exercise | 3,125 | $6.22 | $19,437.50 | (2%) 130.19K to 127.07K | |
| 29-Sep-22 8:45 PM View: | Cho Hannah Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 12,500 | -- | -- | 11% 117.69K to 130.19K | |
| 29-Sep-22 9:02 PM View: | Les Jason Chief Executive Officer Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 46,666 | -- | -- | 1% 3.87M to 3.92M | |
| 29-Sep-22 8:37 PM View: | Yee Colin M. Chief Financial Officer | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 329,995 | -- | -- | 410% 80.58K to 410.57K | |
| 29-Sep-22 8:50 PM View: | Harris Chad Everett EVP, CCO (See Remarks) | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 742,942 | -- | -- | 983% 75.56K to 818.51K | |
| 29-Sep-22 8:58 PM View: | McGonegal Jefferey CFO (Former - See Remarks) | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 323,334 | -- | -- | 57% 566.15K to 889.48K | |
| 29-Sep-22 9:02 PM View: | Les Jason Chief Executive Officer Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 2,971,770 | -- | -- | 330% 900.25K to 3.87M | |
| 29-Sep-22 9:02 PM View: | Les Jason Chief Executive Officer Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 378,334 | -- | -- | 10% 3.92M to 4.3M | |
| 29-Sep-22 8:40 PM View: | Werner Ryan D. SVP, CAO (See Remarks) | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 234,586 | -- | -- | 1050% 22.33K to 256.92K | |
| 29-Sep-22 8:50 PM View: | Harris Chad Everett EVP, CCO (See Remarks) | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 242,000 | -- | -- | 30% 818.51K to 1.06M | |
| 29-Sep-22 8:45 PM View: | Cho Hannah Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 111,411 | -- | -- | 1774% 6.28K to 117.69K | |
| 29-Sep-22 8:59 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 742,942 | -- | -- | 1271% 58.45K to 801.39K | |
| 29-Sep-22 8:59 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 242,000 | -- | -- | 30% 801.39K to 1.04M | |
| 29-Sep-22 9:02 PM View: | Les Jason Chief Executive Officer Director | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Payment of Exercise | 23,333 | $6.22 | $145,131.00 | (< 1%) 4.3M to 4.27M | |
| 29-Sep-22 8:37 PM View: | Yee Colin M. Chief Financial Officer | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Grant | 74,294 | -- | -- | 1182% 6.29K to 80.58K | |
| 29-Sep-22 8:40 PM View: | Werner Ryan D. SVP, CAO (See Remarks) | AspenBio Pharma Inc. (RIOT) | 27-Sep-22 | Option Exercise | 86,000 | -- | -- | 33% 256.92K to 342.92K | |
| 28-Sep-22 9:55 PM View: | Yi Soo Il Benjamin Executive Chairman Director | AspenBio Pharma Inc. (RIOT) | 26-Sep-22 | Grant | 2,971,770 | -- | -- | (43%) 6.94M to 3.97M | |
| 28-Sep-22 9:57 PM View: | d'Ambrosio Lance Varro Director | AspenBio Pharma Inc. (RIOT) | 26-Sep-22 | Option Exercise | 6,250 | -- | -- | 5% 115.19K to 121.44K | |
| 28-Sep-22 9:55 PM View: | Yi Soo Il Benjamin Executive Chairman Director | AspenBio Pharma Inc. (RIOT) | 26-Sep-22 | Option Exercise | 48,416 | -- | -- | < 1% 6.89M to 6.94M | |
| 28-Sep-22 9:57 PM View: | d'Ambrosio Lance Varro Director | AspenBio Pharma Inc. (RIOT) | 26-Sep-22 | Grant | 111,441 | -- | -- | 2972% 3.75K to 115.19K | |
| 28-Sep-22 9:55 PM View: | Yi Soo Il Benjamin Executive Chairman Director | AspenBio Pharma Inc. (RIOT) | 26-Sep-22 | Option Exercise | 378,334 | -- | -- | (10%) 3.97M to 3.59M | |
| 14-Sep-22 8:45 PM View: | McGonegal Jefferey Chief Financial Officer | AspenBio Pharma Inc. (RIOT) | 12-Sep-22 | Payment of Exercise | 3,963 | $8.26 | $32,734.40 | (1%) 347.2K to 343.24K | |
| 14-Sep-22 8:43 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 12-Sep-22 | Payment of Exercise | 27,657 | $8.26 | $228,447.00 | (32%) 86.1K to 58.45K | |
| 14-Sep-22 8:45 PM View: | McGonegal Jefferey Chief Financial Officer | AspenBio Pharma Inc. (RIOT) | 12-Sep-22 | Option Exercise | 9,666 | -- | -- | 3% 337.53K to 347.2K | |
| 14-Sep-22 8:43 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 12-Sep-22 | Option Exercise | 55,315 | -- | -- | 180% 30.79K to 86.1K | |
| 02-Sep-22 8:37 PM View: | d'Ambrosio Lance Varro Director | AspenBio Pharma Inc. (RIOT) | 01-Sep-22 | Sale | 10,000 | $6.69 | $66,900.00 | (73%) 13.75K to 3.75K | |
| 31-Aug-22 7:47 PM View: | d'Ambrosio Lance Varro Director | AspenBio Pharma Inc. (RIOT) | 30-Aug-22 | Option Exercise | 11,250 | -- | -- | 450% 2.5K to 13.75K | |
| 03-Aug-22 5:53 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 02-Aug-22 | Disposition | 6,000 | $7.32 | $43,920.00 | (16%) 36.79K to 30.79K | |
| 03-Aug-22 5:53 PM View: | Jackman William Richard EVP & General Counsel | AspenBio Pharma Inc. (RIOT) | 02-Aug-22 | Option Exercise | 12,000 | -- | -- | 48% 24.79K to 36.79K | |
| 21-Jul-22 7:24 PM View: | Harris Chad Everett EVP, CCO | AspenBio Pharma Inc. (RIOT) | 19-Jul-22 | Payment of Exercise | 8,546 | $5.57 | $47,601.20 | (10%) 84.11K to 75.56K | |
| 21-Jul-22 7:24 PM View: | Harris Chad Everett EVP, CCO | AspenBio Pharma Inc. (RIOT) | 19-Jul-22 | Option Exercise | 28,488 | -- | -- | 51% 55.62K to 84.11K |
